Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery

Annals of Thoracic Surgery

Volumn 95, Issue 6, 2013, Pages 1892-1898

  Vashakidze, Sergo ^a   Gogishvili, Shota ^a   Nikolaishvili, Ketino ^a   Dzidzikashvili, Nino ^a   Tukvadze, Nestani ^a   Blumberg, Henry M ^b,c   Kempker, Russell R ^b  

^a National Center for Tuberculosis and Lung Diseases   (Georgia)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THORAX SURGERY;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; COHORT STUDIES; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; FOLLOW-UP STUDIES; GEORGIA (REPUBLIC); HUMANS; MALE; MIDDLE AGED; PATIENT SAFETY; PNEUMONECTOMY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84878238939     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.03.067     Document Type: Article

References (34)

1. N.R. Gandhi, P. Nunn, and K. Dheda Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis Lancet 375 2010 1830 1843
2. WHO Global tuberculosis control: WHO report 2012 2012 World Health Organization Geneva
3. T. Dalton, P. Cegielski, and S. Akksilp Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study Lancet 380 2012 1406 1417
4. J.H. Grosset, T.G. Singer, and W.R. Bishai New drugs for the treatment of tuberculosis: hope and reality Int J Tuberc Lung Dis 16 2012 1005 1014
5. R.R. Kempker, S. Vashakidze, N. Solomonia, N. Dzidzikashvili, and H.M. Blumberg Surgical treatment of drug-resistant tuberculosis Lancet Infect Dis 12 2012 157 166
6. H.B. Xu, R.H. Jiang, and L. Li Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis J Antimicrob Chemother 66 2011 1687 1695
7. WHO Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/20103. 2010 2010 World Health Organization Geneva
8. British Thoracic Society; Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party BTS guidelines: guidelines on the selection of patients with lung cancer for surgery Thorax 56 2001 89 108
9. WHO Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 Update. WHO/HTM/TB/20116. 2011 2011 World Health Organization Geneva
10. N. Tukvadze, R.R. Kempker, and I. Kalandadze Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis PLoS One 7 2012 e31563
11. J.P. Jacobs, C. Mavroudis, and M.L. Jacobs What is operative mortality? Defining death in a surgical registry database: a report of the STS Congenital Database Taskforce and the Joint EACTS-STS Congenital Database Committee Ann Thorac Surg 81 2006 1937 1941
12. P.A. Harris, R. Taylor, and R. Thielke Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support J Biomed Inform 42 2009 377 381
13. M. Gegia, I. Kalandadze, R.R. Kempker, M.J. Magee, and H.M. Blumberg Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis Int J Infect Dis 16 2012 e391 e396
14. S.D. Ahuja, D. Ashkin, and M. Avendano Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients PLoS Med 9 2012 e1001300
15. K.R. Jacobson, D.B. Tierney, C.Y. Jeon, C.D. Mitnick, and M.B. Murray Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis Clin Infect Dis 51 2010 6 14
16. A.H. Diacon, A. Pym, and M. Grobusch The diarylquinoline TMC207 for multidrug-resistant tuberculosis N Engl J Med 360 2009 2397 2405
17. M.T. Gler, V. Skripconoka, and E. Sanchez-Garavito Delamanid for multidrug-resistant pulmonary tuberculosis N Engl J Med 366 2012 2151 2160
18. FDA. 2012 [cited 2012 January 2, 2012]; Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm. Accessed February 11, 2013.
19. V. Dartois, and C.E. Barry Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis Curr Clin Pharmacol 5 2010 96 114
20. G. Kaplan, F.A. Post, and A.L. Moreira Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity Infect Immun 71 2003 7099 7108
21. H.R. Kim, S.S. Hwang, and H.J. Kim Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis Clin Infect Dis 45 2007 1290 1295
22. T. Törün, K. Tahaoǧlu, and I. Ozmen The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis Int J Tuberc Lung Dis 11 2007 979 985
23. Dalton T, Diem L, Hartline D, eds. Acquired resistance to second-line anti-tuberculosis drugs during MDR-TB treatment in PETTS study. 42nd Union World Conference on Lung Health; 2011 October 29, 2011; Lille, France.
24. R.R. Kempker, A.S. Rabin, and K. Nikolaishvili Additional drug resistance in mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis Clin Infect Dis 54 2011 e51 e54
25. M.W. Kang, H.K. Kim, and Y.S. Choi Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis Ann Thorac Surg 89 2010 1597 1602
26. B.J. Pomerantz, J.C. Cleveland Jr., H.K. Olson, and M. Pomerantz Pulmonary resection for multi-drug resistant tuberculosis J Thorac Cardiovasc Surg 121 2001 448 453
27. J.G. Somocurcio, A. Sotomayor, and S. Shin Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Thorax 62 2007 416 421
28. G. Dravniece, K.P. Cain, T.H. Holtz, V. Riekstina, V. Leimane, and R. Zaleskis Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis Eur Respir J 34 2009 180 183
29. H. Wang, H. Lin, and G. Jiang Pulmonary resection in the treatment of multidrug-resistant tuberculosis: a retrospective study of 56 cases Ann Thorac Surg 86 5 2008 1640 1645
30. Y. Shiraishi, N. Katsuragi, H. Kita, Y. Tominaga, K. Kariatsumari, and T. Onda Aggressive surgical treatment of multidrug-resistant tuberculosis J Thorac Cardiovasc Surg 138 2009 1180 1184
31. S.K. Park, C.M. Lee, J.P. Heu, and S.D. Song A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis Int J Tuberc Lung Dis 6 2002 143 149
32. H.J. Kim, C.H. Kang, and Y.T. Kim Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis Eur Respir J 28 2006 576 580
33. M.D. Iseman, L. Madsen, M. Goble, and M. Pomerantz Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis Am Rev Respir Dis 141 1990 623 625
34. Health Pi. Adjuvant therapies and strategies. The PIH guide to the medical management of multidrug-resistant tuberculosis. United States Partners in Health. 2003:29-32. Available at: http://www.pih.org/library/pih-guide-to- the-medical-management-of-multidrug-resistant-tuberculosis. Accessed November 5, 2012.